Achieng Abura’s son Prince was diagnosed with Sickle Cell Anaemia soon after his birth and all through his life, she had tried her best to get him the best medical treatment available.
Before Achieng Abura passed on, she started a fund drive to raise money for her sick son but unfortunately, she passed on before he could check into hospital.
Recent reports claim that two hospitals in United Kingdom have refused to admit Prince because he isn’t covered by National Health Services.
The fundraiser chairperson of Prince’s M-Changa account revealed the sad news saying that:
“Prince was discharged the day before his mother was laid to rest and traveled to Songhor for the funeral. After a procedure done at Aga Khan Hospital a few days before, he has since stabilized and has been eating and sleeping well and regaining his strength.
In the meantime, Lucie has been to the UK and been in contact with the two hospitals we were referred to by Achieng.
Unfortunately, it seems they will not admit Prince unless he is covered by the NHS (National Health Service) which could only happen if Prince was enrolled in college there. The cost of seeking Sickle Cell treatment without this coverage is beyond us.
We immediately set about looking for alternatives and have been in touch with the Indian High Commission to see if they have any leads that can assist us pursue treatment in India.
Last Saturday we had a fruitful meeting with Prince’s family to deliberate on the way forward and will meet again later this month and they are also helping guide us on what’s best for him.
His Doctor in Nairobi Dr Riyat is also assisting to see if we can find an institution in India that can treat his condition.
We wish to emphasize that there is managing his condition which can be done in Nairobi (even though it may be better managed abroad) and treatment which will mean he will be free of the debilitating conditions of sickle cell and able to lead a full and productive life.
The latter is what we are seeking to do. We do also have a contact in America who is pursuing a few institutions there that specialize in Sickle Cell treatment.”